Clinical Trial Update: RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG) [Phase 2]

View source ↗

Summary

Protocol update for the RECOVER-AUTONOMIC Phase 2 trial detailing IVIG use in long COVID.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: Kanecia Obie Zimmerman | Conditions: Long COVID, Long Coronavirus Disease 2019 (Covid19) | Phase 2 | Status: ACTIVE_NOT_RECRUITING